Skip to main content

rivastigmine

Generic: RIVASTIGMINE TARTRATE·Brand: EXELON, Exelon, RIVASTIGMINE, RIVASTIGMINE TARTRATE

rivastigmine: sourced relationships with 1 company · 1 clinical trial tracked · 1 FDA decision.

rivastigmine evidence translation

What we can confirm

1 FDA record · 1 tracked trial

What it means

Source-backed records connect rivastigmine to RDY; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could rivastigmine → RDY affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Parkinson Disease

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (1)
CompanyDated record stage
DR REDDYS LABORATORIES LTD (RDY)
Reported 2007-10-31 · Current development: unknownSource
Approved
Clinical Trial Registry Records (1)

CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease: A Phase 3 Randomised, Double-blind Placebo-controlled Trial of Rivastigmine to Prevent Falls in Parkinson's Disease.

NCT04226248Registry updated 2025-09-29·Phase 3
Completed

Primary endpoint: Fall rate

InterventionalRandomizedquadruple600 enrolledStarted 2020-01Completion 2025-0738 sites · United KingdomUniversity of Bristol
FDA Decisions1 records
Approval(RDY)FDA ↗
ANDA077130OralCapsule

Frequently asked questions

Which companies have sourced relationships with rivastigmine?

rivastigmine has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD.

How many clinical trials involve rivastigmine?

BioSniper tracks 1 clinical trial involving rivastigmine.

What is rivastigmine's latest FDA decision?

The most recent tracked FDA decision for rivastigmine is Approval, dated October 31, 2007.